No Result
View All Result
  • Private Data
  • Membership options
  • Login
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHubHOT
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Subscribe
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHubHOT
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Home COUNTRY ITALY

Philogen cashes in a 62 mln euro capital increase by Mediobanca's club deal and other investors

Bebeezby Bebeez
May 14, 2019
Reading Time: 3 mins read
in ITALY, PRIVATE EQUITY
Share on FacebookShare on Twitter

Schermata 2019-05-14 alle 06.37.47Philogen spa, a biotech company focused on antibody-based therapies, announced yesterday a 62 million euro capital increase subscribed by new and previous investors (see the press release here).

Among the new investors, figures Equity Partners Investment Club, the club deal of private investors promoted by Mediobanca and led by Roberto Ferraresi, former partner of PAI Partners (see here a previous post by BeBeez) . The club deal is said to have bought an 18% stake in Philogen (see here Repubblica). Mr. Ferraresi then joined the Board of Directors of Philogen, as did Guido Guidi, previously Director of Oncology Europe in Novartis, and Roberto Marsella, former investment director and then head of business development at CDP Equity, former Fondo Strategico Italiano spa, and chairman and managing director and co-promoter of the Spac ALP.I, promoted by Mediobanca, which has recently listed Antares Vision (see here a previous post by BeBeez). Mr. Marsella is on the Board of Directors for his current role in Generali as Head of Portfolio Strategy & Real Estate Partnerships. However, it is not explained in the statement whether Generali is among Philogen’s investors. Leopoldo Zambeletti acted as advisor to Philogen.
The new money will be used to advance pipeline products during clinical development phases. The capital increase will also be used to expand Philogen’s production facilities, allowing large-scale production of antibody products. Currently the company has two products in phase III for oncological indications. Daromun, studied for the treatment of completely resectable stage III B / C melanoma, while Fibromun is being studied in metastatic soft tissue sarcoma. In the pipeline are other products that are in phase I or phase II. The company recently announced collaboration agreements with Celgene, Janssen Biotech and Novartis.
Founded in 1996, Philogen is controlled about 60% by Nerbio owned by the Neri brothers (Duccio, Dario and Giovanni), while the remaining 40% has been in the hands of pharmaceutical entrepreneur Sergio Dompé, who is also an investor in Equity Partners Investment Club.
The Neri brothers are grandchildren of the pharmaceutical industrialist Achille Sclavo. The latter is the founder of the Sienese pharmaceutical company Sclavo, which later became Sclavo-Biocine and came under the control of Guelfo Marcucci, the Florentine entrepreneur who founded Video Music in the 1980s. Sclavo-Biocine was later sold to Novartis in the 1990s. Dario Neri, in particular, is the company’s scientific director, professor of biomacromolecules at the Department of Applied Chemistry of Eth, the Federal Polytechnic of Zurich.
The company had studied a possible ipo first in 2008 and then in 2011 (see the 2011 prospectus here), but in both cases it was later withdrawn.

Gateways to Italy

Gateways to Italy – Offer your services to funds and investors willing to explore opportunities in Italy. Become a partner!

Gateways to Italy – Offer your services to funds and investors willing to explore opportunities in Italy. Become a partner!

by Partner
June 6, 2023

Sign up to our newsletter

SIGN UP

Related Posts

FRANCE

HR Path Expands U.S. Footprint with Acquisition of ClearCourse Consulting

June 24, 2025
PRIVATE DEBT

CIBC Innovation Banking Provides Debt Financing to Support Norvestor’s Acquisition of Swedish Accounting Software Company Wint

June 24, 2025
PRIVATE EQUITY

Leerink Partners Launches London Office, Marking International Expansion

June 24, 2025

ItaHub

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

November 4, 2024
Italy’s SMEs export toward 260 bn euros in 2025

Italy’s SMEs export toward 260 bn euros in 2025

September 9, 2024
With two months to go before the NPL Directive, in Italy the securitization rebus is still to be unraveled

With two months to go before the NPL Directive, in Italy the securitization rebus is still to be unraveled

April 23, 2024
EU’s AI Act, like previous rules on technology,  looks more defensive than investment-oriented

EU’s AI Act, like previous rules on technology, looks more defensive than investment-oriented

January 9, 2024

Co-sponsor

Premium

Funds vying for management consulting firm BIP, a CVC portfolio company. All deals in the sector

Funds vying for management consulting firm BIP, a CVC portfolio company. All deals in the sector

March 6, 2025
Private equity, Italy 2024 closes with 588 deals as for investments and divestments from 549 in 2023. Here is the new BeBeez’s report

Private equity, Italy 2024 closes with 588 deals as for investments and divestments from 549 in 2023. Here is the new BeBeez’s report

February 10, 2025
Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

November 4, 2024
Venture capital investments top €1.3bn in 208 rounds as of Sep30  in Italy. They were €1.5 in all 2023. The new BeBeez Report

Venture capital investments top €1.3bn in 208 rounds as of Sep30 in Italy. They were €1.5 in all 2023. The new BeBeez Report

October 28, 2024
Next Post

Meyer Bergman issues a 117,75 mln euros bond to refinance Le Corti di Baires real estate complex in Milan

Italy's angels & incubators and venture capital weekly roundup. News from Sella, FrescoFrigo, Datrix, Boost Heroes, BarCamper, Orange Fiber, Epicura, Pralina, Doorway, Accenture

EdiBeez srl

C.so Italia 22 - 20122 - Milano
C.F. | P.IVA 09375120962
Aut. Trib. Milano n. 102
del 3 aprile 2013

COUNTRY

Italy
Iberia
France
UK&Ireland
Benelux
DACH
Scandinavia&Baltics

CATEGORY

Private Equity
Venture Capital
Private Debt
Distressed Assets
Real Estate
Fintech
Green

PREMIUM

ItaHUB
Legal
Tax
Trend
Report
Insight view

WHO WE ARE

About Us
Media Partnerships
Contact

INFORMATION

Privacy Policy
Terms&Conditions
Cookie Police

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHub
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Subscribe
  • Login
  • Cart